Stomach Cancer Trial, Recruiting NCT06327386 Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06327386
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with stomach cancer (specifically a type called gastric adenocarcinoma) that has reached a certain stage of spread, meaning it has grown into the stomach wall and/or spread to nearby lymph nodes
  • You had an MRI scan with contrast dye to assess your cancer before starting pre-surgery treatment
  • You had two special types of PET/MRI scans (using substances called 18F-FAPI and 18F-FDG) to re-assess your cancer before surgery
  • You had surgery to remove the cancer after pre-surgery treatment, and tissue samples from the surgery were examined in a lab
  • You are 18 years of age or older
  • You are willing to take part and have signed a consent form agreeing to join the study

Who may not be able to join:

  • You have serious other health conditions that could interfere with your treatment or significantly affect your quality of life during the trial
  • You are taking medications that could interfere with how the study is carried out
  • You are pregnant, breastfeeding, or planning to become pregnant (or cause a partner to become pregnant) during the trial period
  • Your scan images are too poor in quality to be clearly read and assessed by the research team

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8615922970174

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Registry
ClinicalTrials.gov
Start date
1 January 2024
Est. completion
1 January 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Evaluation efficacy of tumor regression level

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov